Skip to main content
. 2022 Jun 6;12:847957. doi: 10.3389/fonc.2022.847957

Table 3.

Multivariate analyses of overall survival for 84 patients with TETs (I).

Clinical factors HR 95%CI P
Sex
 Female
 Male 1.557 .246-9.836 .638
Age (years)
≤58
>58 1.460 .460-4.549 .514
Maximum tumor diameter (cm)
≤5
>5 3.623 1.058-12.403 .040
Surgery 1.360 .387-4.784 .632
Chemotherapy 2.160 .550-8.487 .270
Radiotherapy 1.061 .332-3.386 .921
WHO histological classification 1.261 .453-3.508 .657
Low-risk thymomas/high-risk thymomas/TCs
Masaoka–Koga stage 5.513 1.564-19.434 .008
I/II/III/IV